Drugs and biologicals (6505): United States public contracts since 2024

Updated 8 October 2026 · all lines

Drugs and biologicals (6505): United States public contracts since 2024. Since January 2024 the line carries 158,923 contracts worth $28,207,463,721 from 12 agencies. 514 suppliers share it. $15,055,182,829 in 2024. $13,152,280,892 in 2025.

Assay record ASY-US-0U46D770CF · Cite as: Assay Systems, “Drugs and biologicals (6505): United States public contracts since 2024”, https://assay-systems.com/register/us/line/drugs-and-biologicals/

The line

Since January 2024 the line carries 158,923 contracts worth $28,207,463,721 from 12 agencies. 514 suppliers share it.

$15,055,182,829 in 2024. $13,152,280,892 in 2025.

Suppliers in the line, by value since 2024

7 more suppliers in the line are not listed here, because their register name may be the name of a private person.

The extract for this line

Names every department and buying office behind the figures, who holds each contract now, its value, contract number and end date, the open notices with their closing dates, and the notices behind every figure.

Request extractSee a sample extract Ask about this line

Largest suppliers in the line

Share of the line held by each of its largest suppliers, by value, in the USAspending register.

MCKESSON CORPORATION67.4%AMERISOURCEBERGEN DRUG CORP25.0%ALVOGEN, INC.1.0%CHARTWELL RX LLC0.6%MERCK SHARP & DOHME LLC0.6%ELUSYS THERAPEUTICS INC0.4%FRESENIUS KABI, LLC0.4%GLAXOSMITHKLINE, LLC0.4%DLA TROOP SUPPORT0.3%EXELAN PHARMACEUTICALS INC0.3%

All suppliers in United States, A to Z

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.